Literature DB >> 26216282

Atrial fibrillation coincides with the advanced glycation end product N(ε)-(carboxymethyl)lysine in the atrium.

Mark P V Begieneman1, Liza Rijvers2, Bela Kubat3, Walter J Paulus4, Alexander B A Vonk5, Albert C van Rossum6, Casper G Schalkwijk7, Wim Stooker8, Hans W M Niessen9, Paul A J Krijnen10.   

Abstract

Presence of advanced glycation end products (AGEs) in the heart induces a proinflammatory phenotype. However, the presence of AGEs within atrial tissue of atrial fibrillation (AF) patients is unknown and was analyzed here. Left atrial appendage tissue from 33 AF patients and 9 controls was analyzed for the presence of the major AGEs N(ε)-(carboxymethyl)lysine (CML), VCAM-1, neutrophilic granulocytes, lymphocytes, and macrophages in both the fat tissue and myocardium separately. The total amount of fibrosis was also analyzed. Presence of CML was significantly higher in blood vessels of the left atrial appendage in AF patients as compared to controls, independent of diabetes mellitus. In AF patients, VCAM-1 expression in blood vessels and the numbers of infiltrated neutrophilic granulocytes, lymphocytes, and macrophages significantly increased compared to controls, and were highest in the fat tissue; there was no significant difference in fibrosis compared to controls. Interestingly, total amount of CML and fibrosis in AF and control patients correlated positively. Finally, there was no difference between AF patients based on AF type or surgical indication in the presence of CML, VCAM-1 expression, inflammatory cells, and fibrosis. Our results indicate that in AF the intramyocardial blood vessels of the left atrial appendage have an increased CML presence and proinflammatory status coinciding with a local increase in the number of inflammatory cells.
Copyright © 2015 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26216282     DOI: 10.1016/j.ajpath.2015.04.018

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  10 in total

1.  AGE-RAGE Stress in the Pathophysiology of Atrial Fibrillation and Its Treatment.

Authors:  Kailash Prasad
Journal:  Int J Angiol       Date:  2019-12-09

2.  Renal denervation reduces atrial remodeling in hypertensive rats with metabolic syndrome.

Authors:  Simina-Ramona Selejan; Dominik Linz; Muriel Mauz; Mathias Hohl; Anh Khoa Dennis Huynh; Thimoteus Speer; Jan Wintrich; Andrey Kazakov; Christian Werner; Felix Mahfoud; Michael Böhm
Journal:  Basic Res Cardiol       Date:  2022-07-14       Impact factor: 12.416

3.  Mechanisms of Quercetin against atrial fibrillation explored by network pharmacology combined with molecular docking and experimental validation.

Authors:  Xin Tan; Wei Xian; Xiaorong Li; Yongfeng Chen; Jiayi Geng; Qiyi Wang; Qin Gao; Bi Tang; Hongju Wang; Pinfang Kang
Journal:  Sci Rep       Date:  2022-06-13       Impact factor: 4.996

4.  Analysis of immune cell populations in atrial myocardium of patients with atrial fibrillation or sinus rhythm.

Authors:  Natalia Smorodinova; Martin Bláha; Vojtěch Melenovský; Karolína Rozsívalová; Jaromír Přidal; Mária Ďurišová; Jan Pirk; Josef Kautzner; Tomáš Kučera
Journal:  PLoS One       Date:  2017-02-22       Impact factor: 3.240

5.  Atrial inflammation in different atrial fibrillation subtypes and its relation with clinical risk factors.

Authors:  Linghe Wu; R W Emmens; J van Wezenbeek; W Stooker; C P Allaart; A B A Vonk; A C van Rossum; H W M Niessen; P A J Krijnen
Journal:  Clin Res Cardiol       Date:  2020-02-18       Impact factor: 5.460

6.  Myocardial infarction coincides with increased NOX2 and Nε-(carboxymethyl) lysine expression in the cerebral microvasculature.

Authors:  Amber Korn; Umit Baylan; Suat Simsek; Casper G Schalkwijk; Hans W M Niessen; Paul A J Krijnen
Journal:  Open Heart       Date:  2021-11

Review 7.  Immune remodeling and atrial fibrillation.

Authors:  Yajun Yao; Mei Yang; Dishiwen Liu; Qingyan Zhao
Journal:  Front Physiol       Date:  2022-07-22       Impact factor: 4.755

Review 8.  Oxidative stress and inflammation as central mediators of atrial fibrillation in obesity and diabetes.

Authors:  Basil S Karam; Alejandro Chavez-Moreno; Wonjoon Koh; Joseph G Akar; Fadi G Akar
Journal:  Cardiovasc Diabetol       Date:  2017-09-29       Impact factor: 9.951

9.  The Receptor for Advanced Glycation End Products (RAGE) Is Associated with Persistent Atrial Fibrillation.

Authors:  Terase F Lancefield; Sheila K Patel; Melanie Freeman; Elena Velkoska; Bryan Wai; Piyush M Srivastava; Mark Horrigan; Omar Farouque; Louise M Burrell
Journal:  PLoS One       Date:  2016-09-14       Impact factor: 3.240

10.  Immunohistochemistry of advanced glycation end product Nε-(carboxymethyl)lysine in coronary arteries in relation to cardiac fibrosis and serum N-terminal-pro basic natriuretic peptide in forensic autopsy cases.

Authors:  Makoto Nogami; Tomoaki Hoshi; Yoko Toukairin; Tomomi Arai; Tadashi Nishio
Journal:  BMC Res Notes       Date:  2020-05-12
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.